Nintendo Co. raised its Switch 2 sales forecast on Tuesday, bolstering confidence that the record-breaking console will ...

Saudi Aramco posted a surprise increase in third-quarter profit as a production boost helped mitigate the impact of lower ...

Australia’s central bank held its key interest rate steady in a widely anticipated decision, while Governor Michele Bullock ...

The UK is still in talks with President Donald Trump’s administration for a deal to address US tariffs on steel and whiskey, ...

The UK government is reviewing the location of the South Wales-headquartered Office for National Statistics as it seeks to ...

Good morning. Big Tech inks fresh AI megadeals. Lenskart’s blockbuster IPO stirs valuation jitters. And tax cuts set off a ...

Prime Minister Keir Starmer warned that his government will make “tough but fair decisions” in what’s expected to be a ...

Thematic indexing is Among the fastest-growing segments in the ETF market. At Bloomberg’s ETFs in Depth event in London, ...

David Checketts, the former co-founder of MLS team Real Salt Lake, has acquired a stake in a holding company that owns ...

Welcome to the Mideast Money newsletter, where we chronicle the intersection of money and power in a region that’s become one ...

Prime Minister Giorgia Meloni’s push to rehabilitate Italy as a borrower just advanced another step as Scope Ratings raised ...

Sarepta Therapeutics Inc. shares plunged after a trial designed to confirm the benefits of two of its older drugs failed to show clear patient improvement, raising questions about their future.